Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-049453

Director acquired 1,603 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fust Matthew K Director 2017-08-15 Option exercise +1,603 28,901 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fust Matthew K Director 2017-08-15 Option exercise · Restricted Stock Units −1,603 3,739 D: show line 2 in the form
Loading xslF345X03/doc4.xml…